Hatch-Waxman Litigation
Our lawyers are adept at resolving high-stakes ANDA disputes
Why Cooley
-
Our patent litigators bring decades of experience with litigating Hatch-Waxman matters and have protected billions of dollars in sales for branded pharmaceutical companies
-
We regularly represent research-based pharmaceutical companies on product exclusivity issues, including defending against generic challengers in Hatch-Waxman proceedings
-
We understand the important strategic and regulatory issues that are unique to pharmaceutical litigation
-
Our lawyers advise clients in all aspects of Hatch-Waxman matters, such as reviewing Orange Book-listed patents, preparing for and litigating Paragraph IV challenges and counseling regarding antitrust considerations in settlement agreements
-
At Cooley, our practice seamlessly collaborates with patent prosecutors and life sciences lawyers
-
We’re adept at breaking down complex scientific subject matter to educate and persuade judges
-
Our litigators have PhDs and master’s degrees across scientific disciplines
Recognition
- Corporate Counsel: Top firm for outside counsel for IP litigation
- Law360: Top firm at the Federal Circuit
- BTI Consulting: Top performer in client service
- BTI Consulting: IP Litigation Standouts
- Managing IP: Patent Contentious IP Star
- Managing IP: PTAB Litigation IP Star
- Docket Navigator: Top law firm for PTAB proceedings
Powerful trial and USPTO representation of leading technology and life sciences companies.
Chambers
